To understand how the technology of electronic prescription (e-Rx) can transform the community pharmacist's role through its effects on professionalization. We define professionalization as a pharmaceutical practice centred on clinical activities and made possible by the establishment of professional pharmaceutical services. METHODS. We asked 12 community pharmacists who had participated in an e-Rx pilot project in the Canadian province of Quebec to fill out a qualitative survey on their experience. We then analyzed the pharmacists' perceptions of this new technology using a conceptual framework based on the Davenport typology that presents an exhaustive list of mechanisms, specific to Information Technologies, and thus e-Rx, that can potentially modify information management process and then the role of pharmacists. RESULTS. The pharmacists identified five main mechanisms by which e-Rx could affect the professionalization of community pharmacists: analytical capabilities of the pharmacist and physician, dissemination of knowledge, integration of process tasks, process automation and elimination of intermediaries. These mechanisms can assist pharmacists in exercising their professional judgement by improving the quality of available information and facilitate the execution of prescriptions by improving the quality of orders. E-Rx technology can also strengthen pharmacists' credibility as medication specialists in the eyes of both patients and physicians. Thus, e-Rx can become a collaborative technology to the extent that it improves collaboration between community pharmacists and prescribing physicians. However, the potential benefits of this technology would appear to depend on its characteristics and how prescribing physicians use it. CONCLUSIONS. ERx proposes ways of working and communicating that were previously unimaginable. These new possibilities pave the way for transformations that can significantly increase the professionalization of community pharmacists. The results of this study indicate that community pharmacists have a favourable opinion of e-Rx, believing it can be an ally in their professionalization.
INTRODUCTION
The role of the pharmacist has changed radically in the past century. Originally a careful mixer of ointments and medicines, the apothecary became a distributor of drugs with the industrialization of drug production in the second half of the 20 th century. In the increasingly commercial context, the practice of community pharmacy came to be centred around the distribution of drugs and no longer their preparation, particularly in North America (1, 2) . In response to this commercial trend, the profession's elites initiated a clinical shift in an attempt to reposition the pharmacist around the patient and away from the drug (3). This movement led to the appearance of the concept of pharmaceutical care in the 1980s. According to its traditional definition, pharmacists who practice pharmaceutical care assume responsibility for ensuring that patients achieve pharmacotherapeutic objectives that improve the quality of life of their patients (4, 5) . Over the past twenty years, the training of pharmacists has been revised to produce professionals capable of providing pharmaceutical care.
Some have used the term "reprofessionalization" to describe the process by which pharmacists have attempted to re-centre their activities around the patient and the patient's use of drugs, and away from the drug and its distribution (6) (7) (8) . The professionalization of pharmacists is therefore associated with activities of a clinical nature, as opposed to activities of a technical nature.
In line with these changes, a variety of professional services have been implemented in community pharmacies in the past few decades. These services fall under a variety of categories including therapeutic outcome monitoring, medication management and medication counselling. These initiatives represent an attempt by pharmacists to meet patient's unmet medication related needs, requiring pharmacists to expand their role beyond the distribution of medications and the execution of prescriptions. _________________________________________ Pharmacists use their professional judgement, passing along their knowledge and skills on medications to the prescriber and the patient. An increasing number of studies have shown the clinical and economic benefits of the many professional services offered by community pharmacists, particularly in North America and Europe (9, 10) . However, studies show that these services are not well established in the majority of community pharmacies; instead, prescription execution remains the main focus of practice (11) (12) (13) . Currently, the scope of practice of the community pharmacist is ill-defined, situated somewhere between two ideal types: the health professional, who is altruist and patient-centred, and the shopkeeper, who is focused on efficiency in drug distribution (2, 7, 14) . The commercial context that surrounds the practice in North America accentuates this ambiguity in the minds of patients, other health professionals, and even pharmacists themselves.
The introduction of electronic prescription (e-Rx) technologies in healthcare organizations may be reshaping the field of community pharmacy. In its more restricted definition, electronic prescribing is a process in which the physician uses a computerbased system to prescribe medications (15) . Moreover, advanced e-Rx technologies may include other functionalities to support the various clinicians, including the pharmacists, involved in the medication management process in primary care (see (15) for more details). For example, expert softwares and knowledge database may be included to support physicians in their decision-making (in both clinical and cost aspects); the prescription can be transmitted electronically from the physician to the community pharmacist. Furthermore, e-Rx technology can enables the various clinicians involved in medication management to access complete and up-to-date clinical information on patients, because information from different health professionals can be shared on the network. The result may be improved continuity in patient management (15) .
The majority of studies on e-Rx have been carried out in the hospital context and have focused on the prescribing process of physicians, the system's main users (15) (16) (17) . These studies have revealed both intended and unintended consequences of implementing this technology in healthcare organizations, such as the impact on workflow and roles definition of the various professionals involved in medication management (18, 19) . For the community pharmacist, these effects have rarely been explored. Some experts believe that by facilitating the prescription execution process, e-Rx could be the stepping stone needed to reconcile the functions of medication distribution and provision of professional services (20) . In this sense, e-Rx technology could contribute to the professionalization of community pharmacists by freeing them from a number of the technical tasks associated with prescription execution. However, empirical observations in contexts where e-Rx is being used are rare and have not allowed for any testing of this hypothesis (21) . Moreover, some researchers maintain the opposite, asserting that information technologies (ITs) such as e-Rx could in fact lead to a deprofessionalization of pharmacists in several ways: by codifying and democratizing the expert knowledge of pharmacists, e-Rx could reduce their professional territory and competency; by systematizing the clinical decision-making of pharmacists, e-Rx could decrease their autonomy in exercising their professional judgment; and by enabling tight control of the professional practice of pharmacists, e-Rx could increase the use of disciplinary measures (22) (23) (24) .
To shed light on these issues, we conducted an exploratory case study of 12 pharmacists who had used e-Rx in the actual context of community pharmacy practice. Our objective was to better understand the pharmacists' perceptions of the ways in which e-Rx technology could potentially transform their role through its effects on professionalization. We will first present our analysis model that describes the potential mechanisms through which e-Rx can facilitate or hinder the professionalization of community pharmacists. We will then present our research methods, followed by the results of our analysis of the interviews with community pharmacists. We end with a discussion of the implications of our findings for the professionalization of community pharmacists.
CONCEPTUAL FRAMEWORK
In order to characterize the effects of e-Rx technology on the professionalization of community pharmacists, we used the typology developed by Davenport (25, 26) . The Davenport typology includes nine mechanisms by which an IT can transform an information management process. These mechanisms are described in depth, thereby enabling us to describe in a very detailed way the functions of the e-Rx technology with respect to all of the activities of the community pharmacist. We used this typology to investigate the ways in which e-Rx technology can modify the medication management process in a community pharmacy, and to identify the potential effects of these changes on the professionalization of community pharmacists. But in order to explore how e-Rx can affect the medication management process, we first needed a model of the process. We chose the model developed by Bell et al. (15) , adapting it for the purposes of this study (see Figure 1) . By breaking down the activities of the community pharmacist in a detailed way, we were able to conceptualize the potential effects of e-Rx on these activities, and deduce the probable consequences on the professional role of the pharmacist. Table 1 gives a detailed description of each mechanism, as well as its potential effects, both positive and negative, on the professionalization of pharmacists. When we tried to conceptualize the effects of e-Rx on the professional role of the community pharmacist, we succeeded in operationalizing seven of the nine mechanisms contained in this typology. This clearly shows the significant potential of e-Rx. The two omitted mechanisms were: the sequential mechanism -Changing process sequence, or enabling parallelism -and the geographical mechanism -Coordinating processes across distances -that would not be possible given the strict legal framework governing the professional activities in community pharmacies.
METHODS

Background
An e-Rx technology was implemented as a research project in primary care medical clinics in a large urban area in the Canadian province of Quebec (see (27) ). The participating physicians were provided with a computer that was directly connected to the central database of the MOXXI Project. These databases linked information from the Quebec health insurance agency, known as RAMQ, with data from community pharmacies. This meant the physicians had access to a database containing information on the medical problems, medical visits and actual medication consumption of their consenting patients. When a physician entered a prescription, the expert software would propose dosage regimens and check for any medicationrelated problems (alerts) in the patient's file. Also, the physician was required to enter the treatment indication associated with each medication (s)he prescribed. Two copies of the prescription were printed, one for the patient and one for the physician's files, and the prescription was sent electronically to the secure central database. When the patient arrived at a participating pharmacy, the pharmacist downloaded the prescription on the local computerized dispensing system using a code given on the paper prescription. Twenty-five pharmacies downloaded a total of 458 e-Rxs to their computer system over a 6-month period.
Study procedure
We conducted a qualitative study of the community pharmacists that participated in the e-Rx project (a total of 70 pharmacists). All of the 25 owner pharmacists of participating pharmacies received a letter explaining the objective of the study and asking them to participate. We then contacted them by phone to set up an appointment for an interview. We met with the first eight pharmacists who agreed to take part. We also solicited the participation of salaried pharmacists who were on duty when we interviewed the owner pharmacists. Since we believed this number was sufficient for a qualitative analysis, we did not take any further steps to recruit more subjects. Furthermore, no new theme emerged from the last interviews, indicating that saturation was reached. A total of 12 pharmacists were interviewed for an overall participation rate of 17%. The pharmacists' experiences with electronic prescribing varied greatly: while six of the pharmacists downloaded 15% of all e-Rxs generated during the entire 6-month pilot project, the other six pharmacists tried the system but executed a lower number of e-Rxs, with two pharmacies unable to receive electronic transmissions because of technical problems with the network. In the latter two pharmacies, the pharmacists used the patient's paper copy of the prescription since they could not download the electronic version. All of the pharmacists possessed a good understanding of the new system, having notably received full training for the e-Rx technology.
The 12 community pharmacists participated in semi-directed interviews aimed at documenting their perceptions of the new technology implemented in their workplace. We decided to use the interview as our data collection method because it enables the researcher to study a little known phenomenon in more depth. The interview consisted of open-ended questions on the influence of e-Rx on the day-to-day work of community pharmacists, on their relationship with patients and physicians, and on the role of the community pharmacist. We chose questions that were sufficiently broad that pharmacists could describe their personal experience as well as their expectations with respect to the technology. We did not want to constrain their answers by using targeted questions on the precise functions of e-Rx. This study was approved by the Research Ethics Board of McGill University.
Analysis
We recorded the interviews and then transcribed them in their entirety. A deductive content analysis was performed using the software ATLAS.Ti for the coding procedure. We developed our codebook according to Patton's procedure (28) ; that is, the codes were defined from our open-ended questions and from our initial reading of the interviews. Some additional codes were added during the coding procedure when necessary. We checked the consistency of the codebook by inverse coding after the first codification. This procedure allows the researcher to validate the consistency of the codes by reading all of the quotations associated with a specific code. Every interview was coded twice. We merged the codes into categories of the medication management process and then created comparative tables. The purpose of this step was to compare pharmacists' perceptions about the effect of e-Rx for every activity of the process. Finally, we used the Davenport typology to classify the pharmacists' perceptions according to the different mechanisms. We wrote a preliminary report and sent it to all of the pharmacists interviewed. They sent us their comments, which we reviewed and used to improve the validity of the final analysis.
RESULTS
Based on their experience in the pilot project, the pharmacists identified five mechanisms by which e-Rx technology can influence their professional role: analytical capacity of the pharmacist and physician, dissemination of knowledge, integration of process tasks, process automation and elimination of intermediaries. Table 2 summarizes the effects associated with these mechanisms and gives representative quotes from the pharmacists interviewed. Our analysis of the potential effects associated with these mechanisms, as perceived by the pharmacists interviewed, revealed that two important dimensions of the pharmacist's role are involved: the exercise of professional judgement and the execution of prescriptions. We will elaborate on the effects of the relevant mechanisms in the following sections, according to these two dimensions.
Exercise of professional judgement
According to the pharmacists interviewed, the mechanisms most likely to promote their professionalization are those that improve the quality of information available to them when they are exercising their professional judgement. This can be when they are checking a prescription sent in by a physician (analytical capacity and elimination of intermediaries), or when analyzing the patient's file (integration of process tasks). In fact, all of the pharmacists appreciated the fact that e-Rx enabled them to exercise their professional judgement more adequately when verifying a prescription because a greater amount of information was transmitted with the electronic prescription (quote 1, Table 2 ). The elimination of the patient as an intermediary can also increase the precision of information, thereby increasing the analytical capacity of the pharmacist and facilitating prescription verification (quotes 11.1 to 11.3, Table 2 ). The majority of pharmacists predicted that their interventions with patients (quotes 2.1 and 2.2, Table 2 ) and prescribers (quotes 3.1 and 3.2, Table 2 ) can become more relevant and meaningful as a result.
The integration of clinical information, resulting from the ability to visualize all of a patient's clinical information, can enable community pharmacists to take a more proactive role in managing the pharmacotherapy of patients (quotes 7.1 and 7.2, Table 2 ). For example, half of the pharmacists said they would be willing to make a pharmacotherapeutic treatment decision for certain pathologies if the physician transmitted them the patient's relevant clinical data. Similarly, the majority of pharmacists expressed an interest in monitoring the treatment of chronic conditions by adjusting medication doses, if they had the relevant clinical information to do so. However, the majority of pharmacists believe physicians are opposed to such sharing of clinical data (quote 7.3, Table 2 ). They noted that physicians often want to preserve their professional jurisdiction by refusing to share all clinical information about a patient, such as treatment indication and laboratory test results.
Execution of prescriptions
The majority of pharmacists interviewed believe that e-Rx technology can contribute to their professionalization by facilitating the prescription execution process. One possible mechanism for this effect is process automation, which can reduce the amount of time spent on executing prescriptions. ↑ professionalization due to improvements in the exercise of the pharmacist's professional judgement during prescription execution. ↑ professionalization due to a decrease in prescription errors and a resulting decrease in the amount of time spent on prescription execution. ↓ professionalization due to an increase in the autonomy of physicians when prescribing medications and evaluating patients.
Dissemination of knowledge
E-Rx can increase the quantity of information available to the physician at the time of prescribing by giving the physician access to: 1) clinical data (e.g., drug monographs, protocols, practice guides and treatment algorithms); 2) economic data (e.g., medication costs and insurance coverage).
↑ professionalization due to a decrease in prescription errors and a resulting decrease in the amount of time spent on prescription execution. ↓ professionalization due to an increase in the autonomy of physicians when prescribing medications.
3. Integration of process tasks E-Rx can improve coordination between the different tasks in the medication management process, which are split between physicians, pharmacists and other professionals. All of the patient's clinical information can be combined in a single database, enabling a "virtual" bridging of the gap between professionals. E-Rx represents a first step toward achieving this integration of the activities of the physician and pharmacistboth of whom are involved in medication management-because it makes them converge on a single patient file.
↑ professionalization due to the facilitation of the pharmacist's involvement in different tasks of the medication management process (e.g., evaluation and follow-up).
Process automation E-Rx
can eliminate human-mediated operations in the process. It could lead to the automation of two operations during the prescription execution process: 1) entry of prescriptions in the pharmacist's computer system is automated due to electronic transmission. Therefore, the entry of prescriptions by the assistant or pharmacist is more rapid; 2) prescription interpretation by the assistant or pharmacist is more rapid because the physician uses a standard form for all prescriptions.
↑ professionalization due to a decrease in problems associated with handwritten prescriptions (e.g., illegible handwriting and incomplete information), and a resulting decrease in the amount of time spent on prescription execution.
Elimination of intermediaries E-Rx can eliminate intermediaries in the transfer of information between the physician
↑ professionalization due to a decrease in the problems associated with information ↑ professionalization due to an increase in the pharmacist's ability to intervene with patients in order to manage treatment compliance.
7.
Informational capability E-Rx makes it possible to collect and analyze large data sets on medication management processes and patient populations. Prescriptions become not only retraceable, but also a source of basic data on physician prescribing practices (or prescription profiles), the management processes of pharmacists and patient consumption profiles.
↑ professionalization due to pharmacists now being able to carry out population-level analyses on their physician and patient clienteles (not only for prescriptions dispensed in a pharmacy, but also for the entire catchment population). 
According to half of the pharmacists interviewed, the automation of prescription entry saves time, especially when the prescription includes more than three medications (quotes 8.1 to 8.3, Table 2 ). Some pharmacists felt that such time savings were not significant and that manual entry was just as fast. However, most pharmacists felt that the standard format used in the electronic prescription can reduce the amount of time spent on prescription execution because it leads to the automation of prescription interpretation (quotes 9.1 to 9.3, Table  2 ). This standardization can also decrease the number of telephone calls to the physician for clarification purposes, and therefore increase the relevance and meaningfulness of pharmacist/physician interactions (quotes 10.1 to 10.4, Table 2 ).
Some pharmacists noted that the potential positive effects of e-Rx were dependent on how it is used by physicians. Some pharmacists noted errors on prescriptions generated by the system due to, for example, a lack of correspondence between the format of the electronic prescription and that used in their pharmacy, or the physicians' inexperience with the computerized system (quotes 8.4, 8.5 and 9.4, Table 2 ).
In this case, the automation of prescription entry would not necessarily lead to a time savings vis-à-vis the traditional prescription execution process since the pharmacist must verify e-Rx entries made by the physician (quotes 8.4 and 8.5, Table 2 ). Moreover, from a legal and deontological point of view, the pharmacist is required to validate the details of the prescription (manufacturer, format, dosage, etc.) for the product that he actually serves to the patient. The amount of time spent on prescription execution can therefore actually increase when the pharmacist has to correct entries made by physicians, rather than those made by a pharmacy technician from a written prescription who is more familiar with the pharmacy's usual practices.
E-Rx can also facilitate the prescription execution process by decreasing the number of prescription errors. The majority of the pharmacists mentioned that clinical problems such as drug interactions, allergies and incorrect doses can decrease due to improvements in the analytical capacity of the physician and the dissemination of knowledge (quotes 4.1 and 4.2, Table 2 ). In general, the pharmacists appreciated the fact that the physician can access the patient's pharmacotherapeutic record, knowledge databases on medications and expert software. A number of pharmacists predicted that physicians would not have to call them as much, which they saw as positive (quotes 5.1 and 5.2, Table 2 ). Only two pharmacists saw this technology as a threat to their role as the medication specialist. However, they did not see this threat as a given, but rather as a possibility (quote 5.3, Table 2 ). In the same vein, some pharmacists stressed the limitations of the expert software with respect to their professional expertise, which explains why they did not feel any great threat from e-Rx (quotes 5.4 and 5.5, Table 2 ). The limitations of expert software, according to them, simply reinforce their importance as medication specialists. Finally, some pharmacists predicted that when physicians actually use the expert software or access a patient's complete pharmacotherapeutic record, as is done at the pharmacy, they will better understand the important role of the community pharmacist in medication management (quote 6, Table 2 ).
Two of the seven mechanisms by which e-Rx can potentially modify the practice of pharmacists, tracking capability and informational capability, were not mentioned by the pharmacists as influences on their professionalization. First, the tool did not allow the pharmacist to consult a patient's prescription record without the patient's authorization (for confidentiality reasons). Therefore, none of the pharmacists considered what effects the tracking capability can potentially have on their involvement in monitoring patient treatment compliance. Moreover, the pharmacists did not appear to envision any new possibilities related to informational capability, probably because their usual patient record management software already enables them to do such analyses on their clientele.
DISCUSSION
Our results suggest that e-Rx technology can have a positive effect on the professionalization of community pharmacists by enhancing the quality of information available to them and by improving the quality of prescriptions they execute. These two elements can favour the professionalization of community pharmacists by improving the capacity of pharmacists to exercise their professional judgement, by decreasing the amount of time spent on prescription execution, and by reshaping the image of the community pharmacist. We will now address each of these themes in more detail.
E-Rx and the capacity of pharmacists to exercise their professional judgement
Pharmacists are trained to evaluate a patient's pharmacotherapy based on the patient's condition (e.g., diagnosis, laboratory test results, allergies, life style and preferences). Community pharmacists are required by standards of practice to analyze the patient's pharmacotherapeutic record when executing or renewing a prescription. Currently, the information available to help them when exercising their professional judgement is limited. Often verifying a prescription is just a technical task, limited to validating its legal conformity. E-Rx can provide pharmacists with more precise and complete clinical information, thereby enabling them to exercise their clinical judgement more appropriately during a pharmacotherapeutic evaluation.
Pharmacists also seem ready to participate more actively in managing the pharmacotherapy of patients if they have access to the relevant clinical information. Our results confirm what several studies have already shown, namely that access to clinical information is a prerequisite to facilitating a broadening of the community pharmacist's role (29) (30) (31) . E-Rx, through the mechanism of integration of process tasks, can enable pharmacists to access this information. In this sense, e-Rx is a collaborative technology that facilitates the creation of a team composed of professionals working at different sites. Thus, rather than being confined to just the prescription execution process step, community pharmacists can participate in all aspects of the medication management process in the community (see Figure 1) , from patient evaluation to medication use by patients, in accordance with their pharmacotherapeutic skills. In other words, the pharmacist can be a member of the clinical team, while still remaining in the pharmacy and overseeing the distribution of medications. It turns out that e-Rx can be a technology that paves the way for a greater professionalization of community pharmacists.
The quality of e-Rx and prescription execution
Our results show that e-Rx technology can facilitate the prescription execution process by improving the quality of prescriptions. The standardization of information contained in an e-Rx should limit the technical problems associated with handwritten prescriptions and enable the pharmacist to reduce the time currently spent on clarifying and completing these prescriptions. The validation of the information contained in the e-Rx by expert software, based on the patient's up-to-date pharmacotherapeutic record, can reduce the number of problems that community pharmacists encounter on prescriptions. This result confirms the findings of Buurma et al. (32) , namely that the main determinant of community pharmacist interventions with prescribers and patients is the type of prescription (handwritten versus printed), irrespective of the characteristics of the prescription (e.g., number of medications or types of medications), the patient (e.g., pathology or age), or the prescriber. Thus, e-Rxs would be easier, and require less time, to execute than handwritten prescriptions. Given that pharmacists must intervene to clear up problems for approximately 2% of prescriptions they execute (32, 33) , e-Rx technology can represent a significant gain in productivity.
In addition, the electronic transmission of prescriptions can facilitate the prescription verification process at the pharmacy. However, our results show that these benefits only arise if the information given on the e-Rx is consistent with that in the pharmacy's computer system and with the pharmacist's usual practices. If it is not, it can simply displace the task of the community pharmacist, from verifying the handwritten prescription to verifying the prescription entered by the physician. Some studies on electronic prescribing have noted this displacement. For example, Murray et al. (21) looked at the effects of e-Rx technology on the community pharmacist's work process pre-and post-implantation of the technology. They found that pharmacists spent 45% more time correcting problems associated with prescriptions transmitted electronically than they did handwritten prescriptions. Furthermore, managers of hospital pharmacies reported that up to 50% of prescriptions generated with e-Rx technology had to be cancelled by the pharmacist and redone in the computer system (34) . This doubles the work and does no free up the pharmacist's time for activities of a clinical nature.
Some pharmacists also pointed out that there is no guarantee that the quality of prescriptions will improve with e-Rx technology.
Even if the problems associated with handwritten prescriptions are eliminated, other problems could arise, such as inconsistent dosage sizes, frequencies, or errors in the selection of the drug. Several studies have shown that in the hospital context, e-Rx technologies can indeed generate these types of errors on prescriptions (35, 36) . Verification by the pharmacist therefore becomes even more important, and more time-consuming (37) . Thus the effects of e-Rx on the community pharmacist's execution of prescriptions depend on both the characteristics of the technology, such as flexibility and compatibility with the pharmacist's computer system, and on how the technology is used by prescribers. E-Rx can in fact slow down the prescription execution process and take pharmacists away from their clinical activities. In the field of medical informatics, numerous experts recognize that the majority of e-Rx systems need further refining (15, 38) . If community pharmacists want this technology to contribute to their professionalization, they need to collaborate in this development in order to ensure that systems marketed are well-adapted to their needs and practices (39) .
Prescription execution and the professionalization of community pharmacists
Professional services are difficult to implement in any sustainable way in community pharmacies when there is a shortage of manpower coupled with an increase in the consumption of prescription medications (30, 31, (40) (41) (42) . To handle this challenge, pharmacists are looking for solutions that, like e-Rx, will decrease the time spent on prescription execution. However, there is no guarantee that an increase in the efficacy of prescription execution will translate into an increase in the amount of time spent on clinical activities. Two studies, carried out over twenty years ago, have examined the computerization of community pharmacies and tried to understand how this would alter the activities of community pharmacists (43, 44) . They found that after the system was implemented, pharmacists spent less time on technical activities but not more time on professional activities. So even if the time spent on prescription execution decreases, we cannot know how pharmacists will use this newly available time. They may, for example, simply increase the number of prescriptions processed, without modifying in any significant way their current activities. Consequently, any mechanisms that act to facilitate prescription execution will create an opportunity for the restructuring of the community pharmacist's work, but what direction this transformation will take cannot be known with any certainty.
E-Rx and the image of the community pharmacist
To facilitate the implementation of professional services in community pharmacies, collaboration with prescribing physicians is essential. However, it has been widely documented that most physicians are hesitant about allowing community pharmacists to participate in any areas of pharmacotherapeutic management beyond the executing of prescriptions and the giving of advice and recommendations (6, 8, (45) (46) (47) (48) . It would seem that physicians do not know what to expect from community pharmacists, and the commercial context that structures community pharmacy practice leads to the community pharmacist being seen as more of a shopkeeper than a health professional, which accentuates this ambiguity (14, 49) . Several studies have shown that the key to fostering collaboration is trust, which requires that collaborators recognize each other's role and respect each other (50, 51) . Certainly, our results suggest that e-Rx can have an impact on both of these elements.
First of all, e-Rx can help demystify the professional role of the community pharmacist for the physician by making the information and tools that community pharmacists are already using available to the physician. The physician, by trying out the expert software and seeing firsthand the complexity of patient pharmacotherapeutic profiles, which are based on the real behaviour of patients (e.g., treatment compliance and multiple physician involvement), will be able to better understand the community pharmacist's role and therefore how collaboration could be useful. This democratization of expert medication knowledge can be perceived as a threat by community pharmacists. However, the majority of pharmacists that we interviewed liked the fact that physicians can have access to this information. They also did not believe that computerized systems can replace their expertise on medicines, a reaction that has already been documented (52) .
Secondly, e-Rx can help strengthen the pharmacist's credibility as a specialist in medication use. Pharmacists' interactions with prescribers would become more relevant and meaningful through a number of different mechanisms. For example, the pharmacist would not need to make as many (often irritating) telephone calls to physicians seeking clarification. Moreover, pharmacists can use their clinical skills in pharmacotherapy to make interventions in accordance with information in the patient's record. Interactions between physicians and pharmacists would mainly concern patients and their use of medications, no longer just prescriptions and their characteristics. This should help pharmacists rid themselves of their image as merely the distributors of drugs.
Strengths and limitations
The results presented here need to be interpreted with caution due to the low level of e-Rx use in the pilot project on which these results are based. However, the pharmacists interviewed all possessed a good understanding of the system and all had executed prescriptions generated using the e-Rx technology. It should also be noted that this study was carried out in the early stages of electronic prescribing; perhaps the results will be different after more mature technologies are introduced and users have more fully mastered their use. On the other hand, users are often compelled to reflect on the experience at this stage, making it possible to discern phenomena that become less evident with habit. We believe that using a clear and detailed conceptual framework has allowed us to rigorously determine the potential effects as perceived by professionals who have tried the technology. Also, despite the limited number of pharmacists interviewed, their opinions were sufficiently convergent to make us confident in the strength and external validity of our results. In order to more fully understand this phenomenon, a greater number of pharmacists, practicing in a greater diversity of work environments, should be consulted. It would also be interesting to examine the perceptions of general practitioners and patients on this subject; this would help us better understand the direction that community pharmacy practice will take in the age of electronic prescribing.
CONCLUSION
This study enables us to better understand the perceptions of community pharmacists about the ways in which e-Rx technology could potentially influence their professionalization. Our results show that the technology of e-Rx can facilitate this process, mainly by improving the quality of clinical information available to the community pharmacist. E-Rx can also become a collaborative technology to the extent that it improves collaboration between community pharmacists and prescribing physicians. The automation of prescribing can also facilitate the prescription execution process for the pharmacist, but the specific effects are highly dependent on how compatible the technology is with the current practices of professionals. Finally, e-Rx can contribute to the professionalization of community pharmacists by acting not only on the medication management process in community pharmacy, but also on the image of the pharmacist. In short, this technology can enable pharmacists to solidify their role as a specialist in medication use by improving the relevance and meaningfulness of their interventions with prescribers and patients. In general, e-Rx proposes ways of working and communicating that were previously unimaginable. These new possibilities pave the way for transformations that can have a significant impact on the professionalization of community pharmacists. The results of this study also show that community pharmacists view the influence of e-Rx in a favourable light, believing it can be an ally in their professionalization.
